Report Detail

Pharma & Healthcare Dynamics in Post-pandemic Global Follicle Stimulating Hormone Industry: Supply and Demand, Markets and Prices 2021-2027

  • RnM4306640
  • |
  • 13 April, 2021
  • |
  • Global
  • |
  • 106 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Follicle Stimulating Hormone Market Status and Forecast (2016-2027)
      • 1.3.2 Global Follicle Stimulating Hormone Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Follicle Stimulating Hormone Supply by Company

    • 2.1 Global Follicle Stimulating Hormone Sales Volume by Company
    • 2.2 Global Follicle Stimulating Hormone Sales Value by Company
    • 2.3 Global Follicle Stimulating Hormone Price by Company
    • 2.4 Follicle Stimulating Hormone Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Follicle Stimulating Hormone Market Status by Category

    • 3.1 Follicle Stimulating Hormone Category Introduction
      • 3.1.1 Recombinant FSH
      • 3.1.2 Urinary FSH
    • 3.2 Global Follicle Stimulating Hormone Market by Category
      • 3.2.1 Global Follicle Stimulating Hormone Sales Volume by Category (2016-2021)
      • 3.2.2 Global Follicle Stimulating Hormone Sales Value by Category (2016-2021)
      • 3.2.3 Global Follicle Stimulating Hormone Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Follicle Stimulating Hormone Market Status by End User/Segment

    • 4.1 Follicle Stimulating Hormone Segment by End User/Segment
      • 4.1.1 Infertility Treatment
      • 4.1.2 Assisted Reproductive Technology
    • 4.2 Global Follicle Stimulating Hormone Market by End User/Segment
      • 4.2.1 Global Follicle Stimulating Hormone Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Follicle Stimulating Hormone Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Follicle Stimulating Hormone Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Follicle Stimulating Hormone Market Status by Region

    • 5.1 Global Follicle Stimulating Hormone Market by Region
      • 5.1.1 Global Follicle Stimulating Hormone Sales Volume by Region
      • 5.1.2 Global Follicle Stimulating Hormone Sales Value by Region
    • 5.2 North America Follicle Stimulating Hormone Market Status
    • 5.3 Europe Follicle Stimulating Hormone Market Status
    • 5.4 Asia Pacific Follicle Stimulating Hormone Market Status
    • 5.5 Central & South America Follicle Stimulating Hormone Market Status
    • 5.6 Middle East & Africa Follicle Stimulating Hormone Market Status

    6 North America Follicle Stimulating Hormone Market Status

    • 6.1 North America Follicle Stimulating Hormone Market by Country
      • 6.1.1 North America Follicle Stimulating Hormone Sales Volume by Country (2016-2021)
      • 6.1.2 North America Follicle Stimulating Hormone Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Follicle Stimulating Hormone Market Status

    • 7.1 Europe Follicle Stimulating Hormone Market by Country
      • 7.1.1 Europe Follicle Stimulating Hormone Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Follicle Stimulating Hormone Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Follicle Stimulating Hormone Market Status

    • 8.1 Asia Pacific Follicle Stimulating Hormone Market by Country
      • 8.1.1 Asia Pacific Follicle Stimulating Hormone Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Follicle Stimulating Hormone Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Follicle Stimulating Hormone Market Status

    • 9.1 Central & South America Follicle Stimulating Hormone Market by Country
      • 9.1.1 Central & South America Follicle Stimulating Hormone Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Follicle Stimulating Hormone Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Follicle Stimulating Hormone Market Status

    • 10.1 Middle East & Africa Follicle Stimulating Hormone Market by Country
      • 10.1.1 Middle East & Africa Follicle Stimulating Hormone Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Follicle Stimulating Hormone Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Follicle Stimulating Hormone Distributors
    • 11.3 Follicle Stimulating Hormone Buyers

    12 Global Follicle Stimulating Hormone Market Forecast by Category and by End User/Segment

    • 12.1 Global Follicle Stimulating Hormone Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Follicle Stimulating Hormone Forecast by Category
      • 12.2.1 Global Follicle Stimulating Hormone Sales Volume Forecast by Category
      • 12.2.2 Global Follicle Stimulating Hormone Sales Value Forecast by Category
      • 12.2.3 Global Follicle Stimulating Hormone Price Forecast by Category
    • 12.3 Global Follicle Stimulating Hormone Forecast by End User/Segment
      • 12.3.1 Global Follicle Stimulating Hormone Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Follicle Stimulating Hormone Sales Value Forecast by End User/Segment
      • 12.3.3 Global Follicle Stimulating Hormone Price Forecast by End User/Segment

    13 Global Follicle Stimulating Hormone Market Forecast by Region/Country

    • 13.1 Global Follicle Stimulating Hormone Market Forecast by Region (2022-2027)
      • 13.1.1 Global Follicle Stimulating Hormone Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Follicle Stimulating Hormone Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Merck Serono
      • 14.1.1 Company Information
      • 14.1.2 Follicle Stimulating Hormone Product Introduction
      • 14.1.3 Merck Serono Follicle Stimulating Hormone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 MSD
      • 14.2.1 Company Information
      • 14.2.2 Follicle Stimulating Hormone Product Introduction
      • 14.2.3 MSD Follicle Stimulating Hormone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Gedeon Richter
      • 14.3.1 Company Information
      • 14.3.2 Follicle Stimulating Hormone Product Introduction
      • 14.3.3 Gedeon Richter Follicle Stimulating Hormone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Teva
      • 14.4.1 Company Information
      • 14.4.2 Follicle Stimulating Hormone Product Introduction
      • 14.4.3 Teva Follicle Stimulating Hormone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Techwell
      • 14.5.1 Company Information
      • 14.5.2 Follicle Stimulating Hormone Product Introduction
      • 14.5.3 Techwell Follicle Stimulating Hormone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 GenSci
      • 14.6.1 Company Information
      • 14.6.2 Follicle Stimulating Hormone Product Introduction
      • 14.6.3 GenSci Follicle Stimulating Hormone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Livzon
      • 14.7.1 Company Information
      • 14.7.2 Follicle Stimulating Hormone Product Introduction
      • 14.7.3 Livzon Follicle Stimulating Hormone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Ferring
      • 14.8.1 Company Information
      • 14.8.2 Follicle Stimulating Hormone Product Introduction
      • 14.8.3 Ferring Follicle Stimulating Hormone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 IBSA
      • 14.9.1 Company Information
      • 14.9.2 Follicle Stimulating Hormone Product Introduction
      • 14.9.3 IBSA Follicle Stimulating Hormone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Follicle Stimulating Hormone market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Follicle Stimulating Hormone market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Recombinant FSH
    Urinary FSH

    Segmented by End User/Segment
    Infertility Treatment
    Assisted Reproductive Technology

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    Merck Serono
    MSD
    Gedeon Richter
    Teva
    Techwell
    GenSci
    Livzon
    Ferring
    IBSA


    Summary:
    Get latest Market Research Reports on Follicle Stimulating Hormone. Industry analysis & Market Report on Follicle Stimulating Hormone is a syndicated market report, published as Dynamics in Post-pandemic Global Follicle Stimulating Hormone Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Follicle Stimulating Hormone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,980.00
    $4,470.00
    $5,960.00
    2,139.64
    3,209.46
    4,279.28
    2,506.18
    3,759.27
    5,012.36
    326,757.00
    490,135.50
    653,514.00
    221,533.20
    332,299.80
    443,066.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report